BBlogFlow

Sask. health officials urge public to get flu, COVID-19 shots while infection rate still low - CBC

·3d ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

SaskatchewanAs of Oct. 13, every Saskatchewan resident who is six months and older can get free influenza and COVID-19 vaccines. Only 20% of provincial residents received flu vaccines last yearJeremy Warren · CBC News · Posted: Oct 13, 2026 5:46 PM EDT | Last Updated: October 13Listen to this articleEstimated 3 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Saskatchewan Health Authority medical health officer Dr. Vivian Onaemo receives her influenza and COVID-19 vaccine shots during a media event in Saskatoon on Tuesday, Oct. 13, 2026. (CBC/Jeremy Warren)Saskatchewan health officials launched the province's seasonal immunization campaign in Saskatoon with a plea for the public to get their flu shots. As of Tuesday morning, every Saskatchewan resident who is six months and older can get free influenza and COVID-19 vaccines. While infection rates are currently low across the province, that could quickly change, said Saskatchewan Health Authority (SHA) medical health officer Dr. Vivian Onaemo.

This article is an excerpt. To read the full content, visit the original source. CBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·